Curcumin/Carrier Coprecipitation by Supercritical Antisolvent Route

In this work, polyvinylpyrrolidone (PVP)- and β-cyclodextrin (β-CD)-based composite powders containing curcumin (CURC) were obtained through the supercritical antisolvent (SAS) technique. Pressure, total concentration of CURC/carrier in dimethylsulfoxide, and CURC/carrier ratio effects on the morpho...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefania Mottola (Author), Iolanda De Marco (Author)
Format: Book
Published: MDPI AG, 2024-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_4a0673b4d4374683b9fe97215462da02
042 |a dc 
100 1 0 |a Stefania Mottola  |e author 
700 1 0 |a Iolanda De Marco  |e author 
245 0 0 |a Curcumin/Carrier Coprecipitation by Supercritical Antisolvent Route 
260 |b MDPI AG,   |c 2024-03-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics16030352 
500 |a 1999-4923 
520 |a In this work, polyvinylpyrrolidone (PVP)- and β-cyclodextrin (β-CD)-based composite powders containing curcumin (CURC) were obtained through the supercritical antisolvent (SAS) technique. Pressure, total concentration of CURC/carrier in dimethylsulfoxide, and CURC/carrier ratio effects on the morphology and size of the precipitated powders were investigated. Using PVP as the carrier, spherical particles with a mean diameter of 1.72 μm were obtained at 12.0 MPa, 20 mg/mL, and a CURC/PVP molar ratio equal to 1/2 mol/mol; using β-CD as the carrier, the optimal operating conditions were 9.0 MPa and 200 mg/mL; well-defined micrometric particles with mean diameters equal to 2.98 and 3.69 μm were obtained at molar ratios of 1/2 and 1/1 mol/mol, respectively. FT-IR spectra of CURC/ β-CD inclusion complexes and coprecipitated CURC/PVP powders revealed the presence of some peaks of the active compounds. The stoichiometry of the complexes evaluated through the Job method revealed that β-CD formed inclusion complexes with CURC at a molar ratio equal to 1/1. Dissolution profiles revealed that in comparison with the curve of the pure ingredient, the SAS-processed powders obtained using both PVP and β-CD have an improved release rate. 
546 |a EN 
690 |a inclusion complexes 
690 |a coprecipitated microparticles 
690 |a β-cyclodextrin 
690 |a SAS precipitation 
690 |a fast release 
690 |a supercritical CO<sub>2</sub> 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 16, Iss 3, p 352 (2024) 
787 0 |n https://www.mdpi.com/1999-4923/16/3/352 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/4a0673b4d4374683b9fe97215462da02  |z Connect to this object online.